Journal
SEMINARS IN THROMBOSIS AND HEMOSTASIS
Volume 27, Issue 5, Pages 437-443Publisher
THIEME MEDICAL PUBL INC
DOI: 10.1055/s-2001-17954
Keywords
K5 polysaccharide; chemical and enzymatic modification; sulfation/desulfation; biotechnological heparin; sulfation patterns
Categories
Ask authors/readers for more resources
A process to generate glycosaminoglycans with heparin- and heparan sulfate-like sequences from the Escherichia coli K5 capsular polysaccharide is described. This polymer has the same structure as N-acetylheparosan, the precursor in heparin/ heparan sulfate biosynthesis. The process involves chemical N-deacetylation and N-sulfation, enzymatic conversion of up to 60% of the D-glucuronic acid to L-iduronic acid residues, and chemical O-sulfation. Because direct sulfation afforded unwanted 3-O-sulfated (instead of 2-O-sulfated) iduronic acid residues, a strategy involving graded solvolytic desulfation of chemically oversulfated C5-epimerized sulfaminoheparosans was assessed using persulfated heparin and heparan sulfate as model compounds. The O-desulfation process was shown to increase the anti-factor Xa activity of oversulfated heparin.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available